US · Healthcare

Pharmaron Beijing Co., Ltd. (PHBBF)

Biotechnology

Pharmaron Beijing Co., Ltd. (PHBBF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-25, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for PHBBF

P/E ratio

18.00

Pharmaron Beijing Co., Ltd. (PHBBF) — FAQ

What is PHBBF's P/E ratio?

The price-to-earnings (P/E) ratio for Pharmaron Beijing Co., Ltd. (PHBBF) is 18.00 (data as of 2026-03-25).

Does Pharmaron Beijing Co., Ltd. pay a dividend?

Dividend yield is not available in the current snapshot for Pharmaron Beijing Co., Ltd. (PHBBF). Check the MyAverix Finance app for the latest dividend data.

What sector is Pharmaron Beijing Co., Ltd. in?

Pharmaron Beijing Co., Ltd. (PHBBF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is PHBBF listed on?

PHBBF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)